Tazobactam, Ceftolozane

4 trials 1 recruiting JAnti-infectives

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

1 Recruiting

1 Completed trials

4 Sponsors

4 Countries

Phase III

Phase IV

Phase I (Other)

Phase III: 1 Phase IV: 2 Phase I (Other): 1

Indications tested

Antibiotic level therapeutic 1

Sponsors using this IMP

Assistance Publique Hopitaux De Paris 1 Centre Hospitalier Universitaire De Nantes 1 Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla 1 Merck Sharp & Dohme LLC 1

All trials

4 total

Defining Antibiotic Levels in Intensive care patients (DALI-2) protocol Pending

2024-516232-10-00 Phase IV 1 country Centre Hospitalier Universitaire De Nimes
BICCS - Beta-lactam Intermittent versus Continuous infusion and Combination antibiotic therapy in Sepsis Pending

2024-516849-39-01 Phase III 1 country Assistance Publique Hopitaux De Paris
Efficacy and safety of 7 versus 14 days of antibiotic treatment for bacteremia produced by Pseudomonas aeruginosa: a multicenter, randomized… Recruiting

2023-508441-41-00 Phase IV 1 country Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…
Safety and pharmacokinetics of ceftolozane/tazobactam in pediatric participants with nosocomial pneumonia Ended

2022-501110-56-00 Phase I (Other) 3 countries Merck Sharp & Dohme LLC

Showing 1–4 of 4 trials

← All drugs A–Z